Interferon as treatment for acute hepatitis C. A meta-analysis (Q42977224)

12 November 2017

0 references

Interferon as treatment for acute hepatitis C. A meta-analysis (English)

1 reference

12 November 2017

1 reference

3

1 reference

12 November 2017

C Cammà

1

1 reference

12 November 2017

P Almasio

series ordinal

2

1 reference

12 November 2017

publication date

1 June 1996

1 reference

Digestive Diseases and Sciences

12 November 2017

published in

1 reference

12 November 2017

volume

41

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

1248-1255

1 reference

Antibody to hepatitis C virus in post-transfusion hepatitis

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02088245

Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02088245

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02088245

Alternative perspectives on the biased foundations of medical technology assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02088245

The treatment of acute post-transfusion hepatitis C with recombinant interferon-alpha

21 January 2018

1 reference

12 December 2020

Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast beta-interferon: a preliminary report

1 reference

12 December 2020

Interferon-alpha for chronic hepatitis C: an analysis of pretreatment clinical predictors of response

1 reference

12 December 2020

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

12 December 2020

Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective.

1 reference

12 December 2020

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

12 December 2020

A method for assessing the quality of a randomized control trial

1 reference

12 December 2020

Three cases of posttransfusion hepatitis C treated with interferon-alpha. Confirmation of a carrier state by detection of hepatitis C virus RNA after interferon therapy

1 reference

12 December 2020

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis

1 reference

12 December 2020

Meta-analysis in clinical trials

1 reference

12 December 2020

[Transmission of hepatitis C by accidental needlestick injuries. Evaluation of the risk]

1 reference

12 December 2020

Treatment of acute non-A, non-B hepatitis with interferon alpha-2b

1 reference

12 December 2020

Etiology of fulminant viral hepatitis in Greece

1 reference

12 December 2020

Therapy of chronic post-transfusion non-A, non-B hepatitis with interferon alfa-2b: Swedish experience

1 reference

12 December 2020

Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis

1 reference

12 December 2020

Antibodies to hepatitis C virus in community-acquired acute non-A, non-B hepatitis

1 reference

12 December 2020

Hepatitis C virus markers in patients with acute post-transfusion hepatitis treated with interferon alfa-2b

1 reference

12 December 2020

Transfusion transmitted hepatitis C and non-A, non-B, non-C.

1 reference

12 December 2020

Hepatitis C virus viremia following clinical resolution of acute hepatitis C.

1 reference

12 December 2020

Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis

1 reference

12 December 2020

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

1 reference

12 December 2020

A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C.

1 reference

12 December 2020

Interferon-alpha in acute posttransfusion hepatitis C: a randomized, controlled trial

1 reference

12 December 2020

A prospective study of post-transfusion non-A, non-B (type C) hepatitis following cardiovascular surgery in Taiwan

1 reference

12 December 2020

Interferon alfa in acute posttransfusion hepatitis C: a randomized, controlled trial

1 reference

12 December 2020

Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion

1 reference

12 December 2020

Long-term follow-up of non-A, non-B (type C) post-transfusion hepatitis

1 reference

12 December 2020

A comparison of statistical methods for combining event rates from clinical trials

1 reference

12 December 2020

Resolution of acute hepatitis C after therapy with natural beta interferon

1 reference

12 December 2020

Statistical aspects of the analysis of data from retrospective studies of disease

1 reference

12 December 2020

Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis.

1 reference

12 December 2020

A multicenter randomized controlled trial of recombinant interferon-alpha 2b in patients with acute transfusion-associated hepatitis C.

1 reference

12 December 2020

Blood-borne non-A, non-B hepatitis: hepatitis C.

1 reference

12 December 2020

Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status

1 reference

12 December 2020

Meta-analyses of randomized controlled trials.

1 reference

12 December 2020

Treatment of viral hepatitis C

1 reference

12 December 2020

Role of hepatitis C virus in acute non-A, non-B hepatitis in Greece: A 5-Year prospective study

1 reference

12 December 2020

Therapy of acute hepatitis C with interferon: How good is it really?

1 reference

12 December 2020

Recombinant interferon alpha-2B for acute post-transfusion hepatitis in acute myeloid leukemia

1 reference

12 December 2020

Interferon for non-A, non-B chronic hepatitis

1 reference

12 December 2020

Is there a role for interferon in acute viral hepatitis?

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02088245

1 reference

12 November 2017

1 reference